Washington, D.C. — Today, the Center for American Progress released a new column outlining a series of policy interventions states can pursue to make prescription drugs more affordable for consumers and to save taxpayer dollars. The proposals build on successful interventions already delivering cost savings for states and consumers’ out-of-pocket drug expenses.
Key policy recommendations in the report include:
- Creating drug price transparency programs
- Enacting stricter oversight and regulation of pharmacy benefit managers
- Joining interstate drug purchasing compacts to maximize purchasing power
- Capping consumers’ out-of-pocket costs for prescription drugs
“As Congress has yet to pass meaningful legislation to lower drug prices, it is more important than ever for states to step up to lower costs on a core pocketbook expense for the 62 percent of Americans who report taking at least one prescription,” said Natasha Murphy, director of health policy at CAP and author of the column. “This column serves as a road map for governors and state legislatures to implement proven ideas to lower drug spending and save consumers money.”
Please click here to read: “State Policies To Address Prescription Drug Affordability Across the Supply Chain” by Natasha Murphy
For more questions or to speak with an expert, please contact Colin Seeberger at firstname.lastname@example.org or 202-741-6292.